Press Release

View printer-friendly version Back

Lantheus Holdings Announces Earnings Release and Conference Call Dates for the Fourth Quarter and Full Year 2018

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 5, 2019-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) announced today that it will release its financial results for the fourth quarter and full year of 2018 on Tuesday, February 19, 2019, after the market close. The Company will also provide financial guidance for 2019.

The Company will host a conference call on Wednesday, February 20, 2019, at 8:00 a.m. ET to discuss its financial and operating results. To access the live conference call via telephone, please dial 1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers) and provide passcode 4056488. A live audio webcast of the call will also be available in the Investors section of the Company’s website at www.lantheus.com.

A replay of the audio webcast will be available in the Investors section of the Company’s website approximately two hours after completion of the call and will be archived for 30 days.

About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, including the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension and TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures. The Company is headquartered in North Billerica, Massachusetts with offices in Puerto Rico and Canada. For more information, visit www.lantheus.com.

Source: Lantheus Holdings, Inc.

Investors
Mark Kinarney
978-671-8842

Media
Meara Murphy
978-671-8508